Not medical advice. A record of published research and our assessments of it. The limits

Studies

Every study, review and regulatory document in the collection, newest first. Each links to a page with its population, findings, funding and original source.

01Find

Filter studies

Search titles and summaries

Population match

Topic

Drug

Design

Study tier

Outcome type

Direction

Explained by weight loss?

Industry funded

Peer reviewed

Published from year

Clear filters

5 studies · Download as JSON

Efficacy and Safety of Dual GLP-1/Glucagon Receptor Agonism in Overweight and Obesity: A Class-Specific Systematic Review and Meta-AnalysisMeta-analysis · 2026 · Study tier 2 · Different population · Benefit
Efficacy and safety of mazdutide vs. dulaglutide in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trialsMeta-analysis · 2026 · Facts auto-extracted
Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled TrialsMeta-analysis · 2026 · Study tier 2 · Different population · Unclear
Incretin-Based Dual and Triple Agonists in Overweight or Obese Individuals: A Systematic Review and Meta-AnalysisMeta-analysis · 2026 · Study tier 2 · Different population · Mixed
Comparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trialsMeta-analysis · 2026 · Facts auto-extracted